irasia.com - Investor Relations Asia Pacific
HOME

Pharmaxis Ltd

Press Releases


Please download the latest "Acrobat Reader" to view the PDF.

  • 2014-December-24
  • Pharmaxis Announces Significant Business Milestones Commercialisation of Bronchitol® (Mannitol) in USA, NovaQuest Dispute Settled (in PDF)
  • 2014-November-27
  • Annual General Meeting 27 November 2014 Sydney Chairman's Address (in PDF)
  • 2014-October-30
  • Phase 3 Clinical Trial in Cystic Fibrosis Begins (in PDF)
  • 2014-September-8
  • New Data Analysis from B305 Clinical Trial Presented at ERS (in PDF)
  • 2014-August-28
  • SSAO Inhibitor Ready for the Clinic (in PDF)
  • 2014-August-4
  • Pharmaxis Files Lawsuit against NovaQuest (in PDF)
  • 2014-July-8
  • Update on Timing of Pre-Clinical Partnering Projects (in PDF)
  • 2014-July-8
  • Communication from Financier NovaQuest (in PDF)
  • 2014-June-30
  • Bronchitol Shortlisted for Prestigious Orphan Drug Award (in PDF)
  • 2014-June-18
  • Bronchitol Clinic Experience Highlighted at European CF Meeting (in PDF)
  • 2014-April-15
  • Pharmaxis Quarterly Investor Conference Call (in PDF)
  • 2014-February-17
  • Pharmaxis Quarterly Investor Conference Call (in PDF)
  • 2017
  • 2017 Press Releases
  • 2016
  • 2016 Press Releases
  • 2015
  • 2015 Press Releases
  • 2013
  • 2013 Press Releases
  • 2012
  • 2012 Press Releases
  • 2011
  • 2011 Press Releases
  • 2010
  • 2010 Press Releases
  • 2009
  • 2009 Press Releases
  • 2008
  • 2008 Press Releases
  • 2007
  • 2007 Press Releases
  • 2006
  • 2006 Press Releases
  • 2005
  • 2005 Press Releases
  • 2004
  • 2004 Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2023 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.